Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
Inspire Medical Systems (NYSE: INSP) will report first quarter 2026 financial results after market close on Monday, May 4, 2026.
Rhea-AI Summary
Inspire Medical Systems (NYSE: INSP) will report first quarter 2026 financial results after market close on Monday, May 4, 2026.
A management conference call will begin at 5:00 p.m. Eastern Time the same day and will be webcast via the company's Investor Relations page. Registration is required to ask questions; registrants receive dial-in details and a unique access code. The company recommends registering at least 10 minutes before the call. A replay will be available approximately two hours after the event and archived on the Investor Relations site for two weeks.
Positive
- None.
Negative
- None.
Details
News Market Reaction – INSP
On Apr 6, the day this news came out, INSP closed 1.55% below the previous close.
Data tracked by StockTitan Argus for the Apr 6 session.
Key Figures
- Q4 2025 revenue
- $269.1M
- Reported 4Q25 revenue; described as strong performance
- FY 2025 revenue
- $912.0M
- Full-year 2025 revenue; up 14% vs 2024
- 2026 guidance (revised)
- $950M–$1.0B
- Revised 2026 revenue guidance from Feb 11, 2026 earnings
- 2026 guidance (initial)
- $1,003M–$1,013M
- Initial 2026 revenue guidance from Jan 12, 2026 preliminary results
- Adjusted net income 2025
- $72.1M
- Adjusted net income for full-year 2025 per proxy filings
- Adjusted diluted EPS 2025
- $2.42
- Adjusted diluted EPS for 2025 from proxy materials
- Gross margin 2025
- 85.4%
- Full-year 2025 gross margin highlighted as strong
- Adjusted operating margin 2025
- 7.3%
- Full-year 2025 adjusted operating margin
Previous Earnings date Reports
-
Announced date and webcast details for Q4 and FY 2025 results.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2026 after the close of trading on Monday, May 4. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.
A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q1 2026 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.
If you plan to ask a question, please use the following link: Inspire's Q1 2026 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call.
Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.
About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit www.inspiresleep.com.
Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.